The Naspghan Foundation

“Governing body review of form 990 prior to its filing with the irs, a copy of the form 990 is reviewed by board of directors either electronically or at annual board meeting.”

“Monitoring and enforcement of conflicts policy all foundation officers and directors are required to complete a conflict of interest disclosure and update it on an annual basis via the "disclosure website". The conflict of interest subcommittee of naspghan, a related organization, made up of the chair of clinical care and quality, chair of ethics, and chair of professional development reviews all submitted disclosures. If a conflict exists, participation in board activity may be limited or prohibited.”

“Compensation for the foundation's executive director is set by naspghan, a related organization. Compensation for the development director is determined and reviewed by the foundation board based on industry standards and performance evaluation and review.”

“Public availability of other documents they are available upon request and for inspection at the organization's office.”

“The mission of the north american society for pediatric gastroenterology, hepatology and nutrition is to advance the understanding of normal development, physiology and pathophysiology of diseases of the gastrointestinal tract and liver in children, improve quality of care by fostering the dissemination of this knowledge through scientific meetings, professional and public education, and policy development, and serve as an effective voice for members and the profession.”

“Children with cholestatic liver disease: diagnostics cholestatic jaundice is a rare presentation of various hepatobiliary, metabolic, and genetic disorders. Cholestasis typically presents in the neonatal/infantile period but can also present late in older children or even adults. Early diagnosis and appropriate management of the underlying condition are of paramount importance for optimal prognosis. Diagnosis of cholestasis needs an array of investigations including blood tests, imaging, genetic testing, and invasive procedures like liver biopsy. Liver biopsy is one of the central crucial investigations done in evaluating children with cholestasis, however, can be associated with complications including bleeding. Understanding when to use a liver biopsy in children with cholestasis along with its limitations is extremely important to gain the maximum benefit out of an invasive procedure. Over the last decade, the growth in genetic techniques and the identification of new genes leading to cholestasis in children have evolved significantly and have led to the shrinking of the unidentified etiologies. This webinar addresses the rapidly evolving field of genetic cholestasis and when to perform a liver biopsy, its utility, and limitations. Medical management of chronic pancreatitis in children: maximizing treatment and improving outcomes chronic pancreatitis (cp) in children is associated with significant morbidity and poor quality of life. The incidence of cp in children has risen over the past few decades and is approaching that seen in the adult population. Cp is an inflammatory disease resulting in irreversible changes in the pancreas including acinar cell loss, fibrosis, ductal changes, and calcifications. Patients with cp may suffer from abdominal pain and complications of exocrine pancreatic insufficiency (epi) and diabetes mellitus. Medical management of chronic pancreatitis in children: maximizing treatment and improving outcomes brings together leading experts to discuss how to ensure that childhood cp is recognized early and its sequalae treated promptly. Removing dieting from diet therapies in pediatric gi obesity was declared an epidemic by the cdc in the 1990s, yet significant and sustained weight loss continues to be problematic for americans as a population. Critical factors are often overlooked when addressing obesity such as racial discrimination, disability status, and environmental factors. In conjunction, "weight stigma", or bias that devalues people with larger bodies, can cause increased morbidity and mortality, independent of bmi. As a response, a movement is taking place, known by several names including "anti-diet"intuitive eating". This is an inclusive movement that recognizes one's size as part of his or her identity as much as race, national origin, and sexuality. It considers social, economic, and physical barriers to obesity, rather than assuming lack of willpower or education are the cause. It's about recognizing "diet culturedismantling the anti-fat and pro-thin messages that infiltrate society. This informative and interactive webinar helps healthcare providers recognize weight stigma and promote a positive relationship with food, particularly in patients with gi-related health conditions and those following therapeutic diets. The what, how and ifs of optimizing early childhood growth and long-term outcomes: part one understanding normal growth and development is critically essential for quick recognition and intervention for deviations in childhood growth and nutrient intake practices associated with increased risk for disease and poor long-term health. Nutrient and non-nutrient factors influence health outcomes throughout the lifecycle. This webinar and podcast series, the what, how and ifs of optimizing early childhood growth and long-term outcomes discusses how to implement nutrient and non-nutrient factors that optimize long-term health, recognize childhood growth and nutrient intake patterns”